6 Best Performing Drug Stocks of September   by Zacks on Oct 03, 2016
Company News for September 15, 2016   by Zacks on Sep 15, 2016

SRPT Industry Peers

Company Price Change (%)
Ligand Pharma (LGND)105.620.79 (0.74%)
Juno Therapeutics (JUNO)200.33 (1.68%)
Aviragen Therapeutics (AVIR)1.40.14 (11.11%)
Biocryst Pharma (BCRX)6.250.12 (1.96%)
Gilead Sciences (GILD)73.070.29 (0.4%)
Ptc Therapeutics (PTCT)15.470.11 (0.72%)
Vertex Pharma (VRTX)83.170.78 (0.95%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sangamo BioSciences (SGMO)4.40.45 (11.39%)
Fate Therapeutics (FATE)3.050.29 (10.51%)
Kindred Biosciences (KIN)6.30.55 (9.57%)
Array BioPharma (ARRY)10.870.76 (7.52%)
Amicus Therapeutics (FOLD)5.950.36 (6.44%)
MannKind (MNKD)0.6850.04 (6.19%)
Arbutus Biopharma (ABUS)30.15 (5.26%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jan 14, 2017
CompanyPriceChange (%)
Halozyme Therapeutics (HALO)11.390.47 (3.96%)
Revance (RVNC)21.90.75 (3.31%)
Five Prime Therapeutics (FPRX)48.621.32 (2.64%)
Acceleron Pharma (XLRN)25.530.69 (2.63%)
Stemline Therapeutics (STML)12.950.3 (2.26%)
Arna Pharma (ARNA)1.420.03 (2.07%)
Merrimack Pharma (MACK)3.210.06 (1.83%)
Top losers from Medical-Biomed-Genetics industry
* As of Jan 14, 2017